Filter
1583
Text search:
drug
market
Featured
Recommendations
131
New Publications
465
Language
Document type
No document type
878
Studies & Reports
297
Guidelines
193
Strategic & Response Plan
87
Manuals
75
Fact sheets
22
Training Material
16
Situation Updates
7
Resource Platforms
5
Brochures
1
App
1
Infographics
1
Countries / Regions
India
80
Global
65
Kenya
61
Ethiopia
51
Uganda
48
Western and Central Europe
40
Ghana
37
Nigeria
36
Myanmar / Burma
33
Liberia
30
Bangladesh
30
Sierra Leone
29
Zambia
26
Malawi
26
South Africa
25
Africa
25
Nepal
21
Tanzania
21
Philippines
20
Rwanda
18
Ukraine
17
Latin America and the Carribbean
17
Congo, Democratic Republic of
16
Zimbabwe
15
Cambodia
14
Asia
13
Namibia
12
South–East Asia Region
12
Eastern Europe
12
Indonesia
10
Venezuela
10
Senegal
9
Syria
9
Guinea
8
Brazil
8
Botswana
8
Lesotho
8
Mozambique
7
Burkina Faso
6
Cameroon
6
Thailand
6
China
6
Albania
6
Russia
6
Haiti
5
Eswatini/ Swaziland
5
Eastern Europe and Central Asia
5
Vietnam
5
South Sudan
4
Sudan
4
Colombia
4
Sri Lanka
4
East and Southern Africa
4
West and Central Africa
4
USA
3
Germany
3
Benin
3
Peru
3
North Macedonia
3
Mexico
3
Middle East and North Africa
3
Laos
3
Timor Leste/ East Timor
3
Moldova
3
Georgia
3
Somalia
2
Pakistan
2
Jordan
2
Lebanon
2
Central African Republic
2
Argentina
2
Hungary
2
Libya
2
Western Pacific Region
2
Poland
2
Tajikistan
2
Iran
2
Morocco
1
Iraq
1
Afghanistan
1
Papua New Guinea
1
Switzerland
1
Serbia
1
Bolivia
1
Madagascar
1
Chile
1
Fiji
1
Bhutan
1
Palestine
1
North Korea
1
Italy
1
Canada
1
Qatar
1
Bulgaria
1
Estonia
1
Kyrgyzstan
1
Kazakhstan
1
North America
1
Turkmenistan
1
Jamaica
1
Denmark
1
Maldives
1
Norway
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
652
Clinical Guidelines
101
Public Health
71
Key Resources
54
Pharmacy & Technologies
41
Women & Child Health
40
Capacity Building
13
Toolboxes
HIV
151
Mental Health
135
AMR
131
TB
104
Pharmacy
103
COVID-19
70
NTDs
41
Malaria
30
Planetary Health
28
Health Financing Toolbox
26
Conflict
25
Ebola & Marburg
23
Global Health Education
22
NCDs
22
Disability
18
Refugee
18
Caregiver
16
Rapid Response
13
Cholera
12
2.0 Rapid Response
7
Natural Hazards
6
Social Ethics
4
Polio
3
Specific Hazards
3
Review over the work and challenges of the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC) in combatting counterfeiting of medicines in Nigeria.
World malaria report 2025
recommended
Addressing the threat of antimalarial drug resistance. This year’s report spotlights the growing threat of antimalarial drug resistance. Partial resistance to artemisinin derivatives – the backb
...
Reporting system for the general public - This document aims to provide practical guidelines on how to set up national systems for consumers to report adverse reactions to medicines. The purpose is to help countries set up a well-organized and effective consumer reporting system within their pharmac
...
The Antimicrobial Resistance Benchmark has evaluated for the second time how the most important players in the antibiotic market are addressing the rise of resistance and the global need for appropriate access to antibiotics. Although we can see pro
...
Every day, fake medicines and medical products are sold at street corners, in open air markets or on unregulated websites in several countries in the African Region. These poor quality, unsafe medicines and pharmaceutical products promote drug resis
...
In preparing this paper, the Pharmacovigilance Group of the Pan American Health Organization’s Pan American Network for Drug Regulatory Harmonization (PANDRH) adopted the perspective of PAHO/WHO, which considers Pharmacovigilance, an essential com
...
WHO operational handbook on tuberculosis: module 4: treatment: tuberculosis care and support
recommended
The consolidated guidelines are complemented by an operational handbook which is designed to assist with implementation of the WHO recommendations by Member States, technical partners and others who are involved in the management of patients with DR-TB. The WHO Operational Handbook on Tuberculosis,
...
The report provides a brief introduction to patents and licences and their effect on the market for antiretroviral (ARV) medicines. It gives an overview of the patent landscape with respect to a select number of ARV medicines in developing countries
...
This Implementation Kit (I-Kit), developed by the Health Communication Capacity Collaborative (HC3), helps national and local stakeholders to design country-specific social and behavioural change communication (SBCC) campaigns that address the threat posed by substandard, spurious, falsified and fal
...
This guide is a resource for physicians and other health care professionals who provide care and treatment to patients with drug-resistant tuberculosis.
This document describes the key areas that national governments should consider for the introduction and scale-up of point-of-care (POC) diagnostics within national programmes, as new innovative POC technologies are being introduced into the market.
...
PQM conducted an assessment of the medicine quality assurance and quality control systems in Rwanda during November 9-13, 2009. Medicine quality assurance remains to be developed in Rwanda: the country has neither a medicine regulatory authority (MRA) nor a national medicine quality control laborato
...
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging participation in the WHO Programme for International
...
Antimicrobial resistance is one of the most important threats to the health worldwide. Antimicrobial resistance or drug resistance is the reduction of the pharmaceutical effects of a drug against a
...
Am. J. Trop. Med. Hyg., 106 (Suppl 5), 2022, pp. 56–60. Lymphatic filariasis (LF) is a parasitic disease that is a major cause of chronic disability in the developing world. According to the 2021–2030 road map for neglected tropical diseases (NTDs) published by the World Health Organization (WHO
...
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the dru
...
The MSF qualification scheme is concerned with the pharmaceutical quality assessment for drugs. This procedure is applicable to products for international supply, i.e. products supplied through the MSF procurement centres. This qualification procedure is not applicable for local purchase, i.e. purch
...
Pharmaceutical regulators are at the forefront of ensuring that only safe and effective medicines are authorized and available in the market. This document builds on the recommendations in the above publication and has been prepared to specifically
...
The purpose of this manual is to define a limited number of indicators that will objectively describe the management and use of antimicrobials in hospitals and to provide tools and step-by-step instructions for designing and carrying out an assessment of antibiotic use and management in hospitals. T
...
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spr
...
